Michael S. Weiss
2021 - TG Therapeutics
In 2021, Michael S. Weiss earned a total compensation of $42.7M as Chief Executive Officer and President at TG Therapeutics, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $783,125 |
|---|---|
| Salary | $1,289,985 |
| Stock Awards | $40,593,721 |
| Total | $42,666,831 |
Weiss received $40.6M in stock awards, accounting for 95% of the total pay in 2021.
Weiss also received $783.1K in non-equity incentive plan and $1.3M in salary.
Rankings
In 2021, Michael S. Weiss' compensation ranked 84th out of 12,406 executives tracked by ExecPay. In other words, Weiss earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 84 out of 12,406 | 99th |
Division Manufacturing | 25 out of 5,492 | 100th |
Major group Chemicals And Allied Products | 7 out of 2,368 | 100th |
Industry group Drugs | 5 out of 2,089 | 100th |
Industry Pharmaceutical Preparations | 2 out of 1,536 | 100th |
Pay ratio
| Michael S. Weiss' Pay | $42,666,831 |
|---|---|
| Median Employee's Pay | $184,242 |
| Pay Ratio | 232to 1 |
In 2021, the annual total compensation of Michael S. Weiss was $42,666,831.
The annual total compensation of the median employee at TG Therapeutics was $184,242.
The ratio of Michael S. Weiss' pay to the pay of median employee was therefore 232 to one.
Source: SEC filing on April 29, 2022.
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2021.
2021
Sean Power
TG Therapeutics